Journals / Selçuk Tıp Dergisi / 2018 / Cilt: 34 - Sayı: 3

The Efficacy of Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus

Keratokonus Progresyonunun Önlenmesinde Korneal Kollajen Çapraz Bağlama Tedavisinin Etkinliği

Pages
106–111
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Long-term, prospective, large studies are needed to display the long-term effectiveness of this treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of the study was to investigate effectiveness of corneal collagen cross-linking treatment in patients with progressive keratoconus.
📊
Key Findings & Data:Patients and Methods: Ten patients (6 female and 4 male) who showed progression in the parameters of Keratoconus were included in the study.
💡
Conclusion & Impact:Long-term, prospective, large studies are needed to display the long-term effectiveness of this treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of the study was to investigate effectiveness of corneal collagen cross-linking treatment in patients with progressive keratoconus. Patients and Methods: Ten patients (6 female and 4 male) who showed progression in the parameters of Keratoconus were included in the study. Complete ophthalmological examinations including uncorrected and best-corrected visual acuities (UCVA and BCVA), slit-lamp anterior and posterior segment investigation and intraocular pressure was performed in all patients. Corneal topographic measurements were done by Sirius Corneal Topography system. All patients underwent an intervention of corneal collagen crosslinking procedure with riboflavin and UV-A. Results: Sim K max value of all patients in topographic measurement decreased (mean 0,95±0,22 D) after 6 month follow-up. The value of sim K min decreased (mean 0.39 D) in 8 patients, while it showed no change in 2 patients (20%). A decrease of mean of 10,1±1,37µm central corneal thickness was observed. In 6 eyes (60%), BCVA showed improvement when compared to the baseline values, while BCVA in 4 (40%) eyes remained stable during the follow-up period. Conclusion: Corneal collagen cross-linking treatment as a first applications of our clinic using Apollon device seems to be effective in prevention of keratoconus progression according to our experience in our small series. Long-term, prospective, large studies are needed to display the long-term effectiveness of this treatment.

Özet

Amaç: İlerleyici keratokonusu bulunan hastalarda korneal kollajen çapraz bağlama tedavisinin etkinliğinin araştırılması amaçlanmıştır Hastalar ve Yöntem: Çalışmaya altısı bayan, dördü erkek 10 hastanın keratokonus değerlerinde ilerleme saptanan 10 gözü dahil edilmiştir. Tüm hastaların düzeltilmemiş ve en iyi düzeltilmiş görme keskinlikleri, biyomikroskobik muayene, göz içi basınç ölçümü içeren tam oftalmolojik muayeneleri yapılmış ve korneal topografi ölçümleri gerçekleştirilmiştir. Topografi ölçümleri Sirius Korneal topografi cihazı ile gerçekleştirildi. Tüm hastalara riboflavin/UV-A ile kornea kollajen çapraz bağlama işlemi gerçekleştirilmiştir. Bulgular: 6 aylık takip süresinin sonunda, korneal topografide, tüm hastaların Sim K max değeri ortalama 0,95±0,22 D azalma göstermiştir. Sim K min değeri ise 8 gözde (%80) azalırken (ortalama 0,39 D) 2 gözde (%20) değişiklik olmamıştır. Santral kornea kalınlıkları ise ortalama 10,1±1,37µm azalma göstermiştir. En iyi düzeltilmiş görme keskinlikleri tedavi öncesi ve sonrasına göre incelendiğinde 6 hastada (%20) tedavi öncesine göre artış gösterdiği, 4 hastada (%40) ise görme keskinliklerinin sabit kaldığı tespit edilmiştir. Sonuç: Apollon cihazı ile kliniğimizin ilk uygulamalarının sonuçlarına göre korneal kollajen çapraz bağlama tedavisi keratokonus progresyonunu durdurmada etkili bir yöntem olarak görünmektedir. Tedavinin kalıcılığının değerlendirilebilmesi için uzun dönemli geniş serili, prospektif çalışmalara ihtiyaç duyulmaktadır

🔖

Cite This Article

İNAN, S., ÇETRİNKAYA, E., DUMAN, R., KUTKUKSAMAN, B., DOĞAN, M., YAVAŞ, G. F. (2018). The Efficacy of Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus. Selçuk Tıp Dergisi, Cilt: 34 - Sayı: 3, 106–111. https://ajindex.com/articles/319090

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related non-inflammatory corneal thinning disorders. Surv Ophthalmol 1984;28:293-322
  2. Lembach RG. Use of contact lenses for management of keratoconus. Ophthalmol Clin North Am 2003;16:383-94
  3. Alio JL, Shabayek MH, Belda JI, et al. Analysis of results related to good and bad outcomes of INTACS implantation for keratoconus correction. J Cataract Refract Surg 2006;32:756-61
  4. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a induced collagen crosslinking for treatment of keratoconus. Am J Ophthalmol 2003;135:620-7
  5. Wollensak G, Spoerl E, Seiler T. Treatment of keratoconus by collagen crosslinking. Ophthalmologe 2003;100:44-9
  6. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res 1998;66:97-103
  7. Spoerl E, Seiler T. Techniques for stiffening the cornea. J Refract Surg 1999;15:711-3
  8. Wollensak G. Crosslinking treatment of progressive keratoconus: New hope. Curr Opinn Ophthalmol 2006;17:356- 60
  9. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-Ainduced cross-linking. J Cataract Refract Surg 2003;29:1780- 5
  10. Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998;42:297- 319
  11. Witta-Silva C, Whiting M, Lamoureux E, et al. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: Preliminary results. J Refract Surg 2008;24:720-5
  12. Kymionis GD, Diakonis VF, Kalyvianaki M, et al. One-year follow-up of corneal confocal microscopy after corneal crosslinking in patients with post laser in situ keratosmileusis ectasia and keratoconus. Am J Ophthalmol 2009;147:774-8
  13. Coskunseven E, Jankov MR, Hafezi F. Contralateral eye study of corneal collagen cross-linking with riboflavin and UV-A irradiation in patients with keratoconus. J Refract Surg 2009;25:371-6
  14. Gümüş K, Mirza E, Erkılıç K, et al. İlerleyici tip keratokonus hastalarında Ribo avin/UV-A ile çapraz bağlama tedavisinin erken dönem sonuçları. TOD Dergisi 2010;40:18-247
  15. Vinciguerra P, Albe E,Trazza S, et al.Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. Ophthalmology 2009;116:369-78
  16. Greenstein SA, Shah VP, Fry KL, et al. Corneal thickness changes after corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results. J Cataract Refract Surg 2011;37:691-700
  17. Poli M, Cornut PL, Balmitgere T, et